Semaglutide protects against diabetes‐associated cardiac inflammation via Sirt3‐dependent RKIP pathway
Semaglutide exerted cardioprotective effects against diabetic heart failure by alleviating cardiac inflammation through Sirt3-dependent RKIP signalling pathway.
Authors
- Yun Zhao (ORCID: https://orcid.org/0000-0002-9075-1478)
- Qiwei Zhai (ORCID: https://orcid.org/0000-0002-9617-7403)
- Changlin Zhai (ORCID: https://orcid.org/0000-0002-0593-6102)
- Dong Huang (ORCID: https://orcid.org/0000-0003-2872-6164)
- Junbo Ge (ORCID: https://orcid.org/0000-0002-8765-4941)
- Yan Yan (ORCID: https://orcid.org/0000-0002-0455-7450)
- Huilin Hu (ORCID: https://orcid.org/0000-0003-1619-4682)
- Wang Ai (ORCID: https://orcid.org/0009-0007-9606-9094)
- Kaibin Lin
Institutions
- Sun Yat-sen University (CN)
- Fudan University (CN)
- ShanghaiTech University (CN)
- Jiaxing University (CN)
- Shanghai Institute of Nutrition and Health (CN)
- Zhongshan Hospital (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Shanghai Sixth People's Hospital (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- British Journal of Pharmacology
- Published
- 2024-12-22
- DOI
- https://doi.org/10.1111/bph.17327
- Citations
- 23
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 8.23
Funders
- National Natural Science Foundation of China
- Fudan University
- Shanghai Jiao Tong University
- Shanghai Shen Kang Hospital Development Center
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- School of Medicine, Shanghai Jiao Tong University